Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bexotegras
2. Bexotegras [inn]
3. Pln-74809
4. Qcv154pft4
5. (2s)-4-(2-methoxyethyl-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic Acid
6. (s)-4-((2-methoxyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic Acid
7. 2376257-44-0
8. Butanoic Acid, 4-((2-methoxyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(4-quinazolinylamino)-, (2s)-
9. (2s)-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(quinazolin-4-ylamino)butanoic Acid
10. Unii-qcv154pft4
11. Schembl21329445
12. Gtpl12108
13. Us10793564, Compound 5
14. Bdbm465216
15. Pln-74809 [who-dd]
16. Pln74809
17. Us10793564, Compound 55
18. Hy-137561
19. Cs-0140405
| Molecular Weight | 492.6 g/mol |
|---|---|
| Molecular Formula | C27H36N6O3 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 14 |
| Exact Mass | 492.28488903 g/mol |
| Monoisotopic Mass | 492.28488903 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 655 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
85
PharmaCompass offers a list of Bexotegrast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bexotegrast manufacturer or Bexotegrast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bexotegrast manufacturer or Bexotegrast supplier.
PharmaCompass also assists you with knowing the Bexotegrast API Price utilized in the formulation of products. Bexotegrast API Price is not always fixed or binding as the Bexotegrast Price is obtained through a variety of data sources. The Bexotegrast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bexotegrast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bexotegrast, including repackagers and relabelers. The FDA regulates Bexotegrast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bexotegrast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bexotegrast supplier is an individual or a company that provides Bexotegrast active pharmaceutical ingredient (API) or Bexotegrast finished formulations upon request. The Bexotegrast suppliers may include Bexotegrast API manufacturers, exporters, distributors and traders.
Bexotegrast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bexotegrast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bexotegrast GMP manufacturer or Bexotegrast GMP API supplier for your needs.
A Bexotegrast CoA (Certificate of Analysis) is a formal document that attests to Bexotegrast's compliance with Bexotegrast specifications and serves as a tool for batch-level quality control.
Bexotegrast CoA mostly includes findings from lab analyses of a specific batch. For each Bexotegrast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bexotegrast may be tested according to a variety of international standards, such as European Pharmacopoeia (Bexotegrast EP), Bexotegrast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bexotegrast USP).
